The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats

Four sessions of immobilization stress induced anxiogenic behavioral disorders in rats, which were accompanied by decreases in glucocorticoid sensitivity, increases in MAO-B activity in brain tissue, increases in tolerance to glucose loading, and decreases in resistance to acute hypoxia. Alloxan dia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience and behavioral physiology 2003-07, Vol.33 (6), p.595-599
Hauptverfasser: Volchegorskii, I A, Tseilikman, V E, Ship, S A, Bubnov, N V, Sinitskii, A I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 599
container_issue 6
container_start_page 595
container_title Neuroscience and behavioral physiology
container_volume 33
creator Volchegorskii, I A
Tseilikman, V E
Ship, S A
Bubnov, N V
Sinitskii, A I
description Four sessions of immobilization stress induced anxiogenic behavioral disorders in rats, which were accompanied by decreases in glucocorticoid sensitivity, increases in MAO-B activity in brain tissue, increases in tolerance to glucose loading, and decreases in resistance to acute hypoxia. Alloxan diabetes was accompanied by a decrease in behavioral activity of rats in the open field test, with an increase in cerebral MAO-B activity. Preceding anxiogenic stress increased the extent of the alloxan-induced increase in cerebral MAO-B activity and the accompanying abnormalities in the rats' behavior, and also potentiated the hyperglycemic effect of alloxan.
doi_str_mv 10.1023/A:1023934804835
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71253558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>347821861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c195t-5f2d3e0e86518939491fbc697a143afe61b16fabf82d0a9a4ecdf28b887fbfb33</originalsourceid><addsrcrecordid>eNpdkM1LAzEQxYMoWqtnbxI8eOpqstlsEm-l-AUFLxW8LdnspEa2m7rJSvvfm9J6cRh4zJsfj2EQuqLkjpKc3U8fdqJYIUkhGT9CI8oFy6RSH8doRIgSGeGFOkPnIXwRQoSQ5BSd0YLzPPUIfS8-AYO1YGLA3mLdbZxfQucMDrGHkMwOL9vBeOP76Ix3DQ7QBRfdj4vbyX4XAEffQq87A5OU0WDdtn6jO5wiXIg7H7s06Rgu0InVbYDLg47R-9PjYvaSzd-eX2fTeWao4jHjNm8YEJAlp1IxVShqa1MqoWnBtIWS1rS0urYyb4hWugDT2FzWUgpb25qxMbrd5657_z1AiNXKBQNtqzvwQ6gEzTnjXCbw5h_45Ye-S7dVeSouSlom6PoADfUKmmrdu5Xut9XfJ9kvhzN3eA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222257616</pqid></control><display><type>article</type><title>The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Volchegorskii, I A ; Tseilikman, V E ; Ship, S A ; Bubnov, N V ; Sinitskii, A I</creator><creatorcontrib>Volchegorskii, I A ; Tseilikman, V E ; Ship, S A ; Bubnov, N V ; Sinitskii, A I</creatorcontrib><description>Four sessions of immobilization stress induced anxiogenic behavioral disorders in rats, which were accompanied by decreases in glucocorticoid sensitivity, increases in MAO-B activity in brain tissue, increases in tolerance to glucose loading, and decreases in resistance to acute hypoxia. Alloxan diabetes was accompanied by a decrease in behavioral activity of rats in the open field test, with an increase in cerebral MAO-B activity. Preceding anxiogenic stress increased the extent of the alloxan-induced increase in cerebral MAO-B activity and the accompanying abnormalities in the rats' behavior, and also potentiated the hyperglycemic effect of alloxan.</description><identifier>ISSN: 0097-0549</identifier><identifier>EISSN: 1573-899X</identifier><identifier>DOI: 10.1023/A:1023934804835</identifier><identifier>PMID: 14552552</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Alloxan - pharmacology ; Animals ; Anxiety - physiopathology ; Behavior ; Brain - drug effects ; Brain - metabolism ; Cytokines ; Diabetes ; Diabetes Mellitus, Experimental - physiopathology ; Enzymes ; Glucocorticoids - metabolism ; Glucose ; Glucose - metabolism ; Hypoxia ; Hypoxia - metabolism ; Monoamine Oxidase - drug effects ; Monoamine Oxidase - metabolism ; Rats ; Restraint, Physical ; Stress, Psychological - metabolism</subject><ispartof>Neuroscience and behavioral physiology, 2003-07, Vol.33 (6), p.595-599</ispartof><rights>Copyright Kluwer Academic Publishers Jul 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c195t-5f2d3e0e86518939491fbc697a143afe61b16fabf82d0a9a4ecdf28b887fbfb33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14552552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Volchegorskii, I A</creatorcontrib><creatorcontrib>Tseilikman, V E</creatorcontrib><creatorcontrib>Ship, S A</creatorcontrib><creatorcontrib>Bubnov, N V</creatorcontrib><creatorcontrib>Sinitskii, A I</creatorcontrib><title>The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats</title><title>Neuroscience and behavioral physiology</title><addtitle>Neurosci Behav Physiol</addtitle><description>Four sessions of immobilization stress induced anxiogenic behavioral disorders in rats, which were accompanied by decreases in glucocorticoid sensitivity, increases in MAO-B activity in brain tissue, increases in tolerance to glucose loading, and decreases in resistance to acute hypoxia. Alloxan diabetes was accompanied by a decrease in behavioral activity of rats in the open field test, with an increase in cerebral MAO-B activity. Preceding anxiogenic stress increased the extent of the alloxan-induced increase in cerebral MAO-B activity and the accompanying abnormalities in the rats' behavior, and also potentiated the hyperglycemic effect of alloxan.</description><subject>Alloxan - pharmacology</subject><subject>Animals</subject><subject>Anxiety - physiopathology</subject><subject>Behavior</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Experimental - physiopathology</subject><subject>Enzymes</subject><subject>Glucocorticoids - metabolism</subject><subject>Glucose</subject><subject>Glucose - metabolism</subject><subject>Hypoxia</subject><subject>Hypoxia - metabolism</subject><subject>Monoamine Oxidase - drug effects</subject><subject>Monoamine Oxidase - metabolism</subject><subject>Rats</subject><subject>Restraint, Physical</subject><subject>Stress, Psychological - metabolism</subject><issn>0097-0549</issn><issn>1573-899X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkM1LAzEQxYMoWqtnbxI8eOpqstlsEm-l-AUFLxW8LdnspEa2m7rJSvvfm9J6cRh4zJsfj2EQuqLkjpKc3U8fdqJYIUkhGT9CI8oFy6RSH8doRIgSGeGFOkPnIXwRQoSQ5BSd0YLzPPUIfS8-AYO1YGLA3mLdbZxfQucMDrGHkMwOL9vBeOP76Ix3DQ7QBRfdj4vbyX4XAEffQq87A5OU0WDdtn6jO5wiXIg7H7s06Rgu0InVbYDLg47R-9PjYvaSzd-eX2fTeWao4jHjNm8YEJAlp1IxVShqa1MqoWnBtIWS1rS0urYyb4hWugDT2FzWUgpb25qxMbrd5657_z1AiNXKBQNtqzvwQ6gEzTnjXCbw5h_45Ye-S7dVeSouSlom6PoADfUKmmrdu5Xut9XfJ9kvhzN3eA</recordid><startdate>200307</startdate><enddate>200307</enddate><creator>Volchegorskii, I A</creator><creator>Tseilikman, V E</creator><creator>Ship, S A</creator><creator>Bubnov, N V</creator><creator>Sinitskii, A I</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7TK</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200307</creationdate><title>The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats</title><author>Volchegorskii, I A ; Tseilikman, V E ; Ship, S A ; Bubnov, N V ; Sinitskii, A I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c195t-5f2d3e0e86518939491fbc697a143afe61b16fabf82d0a9a4ecdf28b887fbfb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Alloxan - pharmacology</topic><topic>Animals</topic><topic>Anxiety - physiopathology</topic><topic>Behavior</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Experimental - physiopathology</topic><topic>Enzymes</topic><topic>Glucocorticoids - metabolism</topic><topic>Glucose</topic><topic>Glucose - metabolism</topic><topic>Hypoxia</topic><topic>Hypoxia - metabolism</topic><topic>Monoamine Oxidase - drug effects</topic><topic>Monoamine Oxidase - metabolism</topic><topic>Rats</topic><topic>Restraint, Physical</topic><topic>Stress, Psychological - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Volchegorskii, I A</creatorcontrib><creatorcontrib>Tseilikman, V E</creatorcontrib><creatorcontrib>Ship, S A</creatorcontrib><creatorcontrib>Bubnov, N V</creatorcontrib><creatorcontrib>Sinitskii, A I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience and behavioral physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Volchegorskii, I A</au><au>Tseilikman, V E</au><au>Ship, S A</au><au>Bubnov, N V</au><au>Sinitskii, A I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats</atitle><jtitle>Neuroscience and behavioral physiology</jtitle><addtitle>Neurosci Behav Physiol</addtitle><date>2003-07</date><risdate>2003</risdate><volume>33</volume><issue>6</issue><spage>595</spage><epage>599</epage><pages>595-599</pages><issn>0097-0549</issn><eissn>1573-899X</eissn><abstract>Four sessions of immobilization stress induced anxiogenic behavioral disorders in rats, which were accompanied by decreases in glucocorticoid sensitivity, increases in MAO-B activity in brain tissue, increases in tolerance to glucose loading, and decreases in resistance to acute hypoxia. Alloxan diabetes was accompanied by a decrease in behavioral activity of rats in the open field test, with an increase in cerebral MAO-B activity. Preceding anxiogenic stress increased the extent of the alloxan-induced increase in cerebral MAO-B activity and the accompanying abnormalities in the rats' behavior, and also potentiated the hyperglycemic effect of alloxan.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>14552552</pmid><doi>10.1023/A:1023934804835</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0097-0549
ispartof Neuroscience and behavioral physiology, 2003-07, Vol.33 (6), p.595-599
issn 0097-0549
1573-899X
language eng
recordid cdi_proquest_miscellaneous_71253558
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Alloxan - pharmacology
Animals
Anxiety - physiopathology
Behavior
Brain - drug effects
Brain - metabolism
Cytokines
Diabetes
Diabetes Mellitus, Experimental - physiopathology
Enzymes
Glucocorticoids - metabolism
Glucose
Glucose - metabolism
Hypoxia
Hypoxia - metabolism
Monoamine Oxidase - drug effects
Monoamine Oxidase - metabolism
Rats
Restraint, Physical
Stress, Psychological - metabolism
title The effects of anxiogenic stress on glucocorticoid sensitivity, glucose tolerance, and alloxan resistance in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A59%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20anxiogenic%20stress%20on%20glucocorticoid%20sensitivity,%20glucose%20tolerance,%20and%20alloxan%20resistance%20in%20rats&rft.jtitle=Neuroscience%20and%20behavioral%20physiology&rft.au=Volchegorskii,%20I%20A&rft.date=2003-07&rft.volume=33&rft.issue=6&rft.spage=595&rft.epage=599&rft.pages=595-599&rft.issn=0097-0549&rft.eissn=1573-899X&rft_id=info:doi/10.1023/A:1023934804835&rft_dat=%3Cproquest_pubme%3E347821861%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222257616&rft_id=info:pmid/14552552&rfr_iscdi=true